What's breaking now, across thousands of outlets.
An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease non-infectious uveitis.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
Relief could be in sight for millions of people living with the pain and discomfort of irritable bowel syndrome (IBS) thanks to a specially formulated fiber that's been created and trialed by…
New research has found parents, guardians and nongamers may struggle to recognize video game loot boxes, their defining features and the digital receipts linked to purchases.
Scientists found millions of acres of overlooked conservation land, from sacred sites to watershed reserves. The world may hit its 2030 goal, just not in the right places.
From orbit, today’s space-based laser instruments measure Earth’s forests and terrain one narrow line at a time. Between those lines are enormous gaps that include millions of acres of land scientists…
In recent years, researchers at the University of Eastern Finland have been both leading and contributing to collaborative genome projects.
Here are the key things investors need to know to start the trading day.
